Clarification: 510k is premarket notification; it provides no patent or FDA approval

MLA

Craig G, Burkhart. “Clarification: 510k Is Premarket Notification; It Provides No Patent or FDA Approval.” Journal of Drugs in Dermatology : JDD, vol. 7, no. 2, Mar. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c994da3d96aa7eb2bc4f3a341c960911&authtype=sso&custid=ns315887.

APA

Craig G, B. (2008). Clarification: 510k is premarket notification; it provides no patent or FDA approval. Journal of Drugs in Dermatology : JDD, 7(2).

Chicago

Craig G, Burkhart. 2008. “Clarification: 510k Is Premarket Notification; It Provides No Patent or FDA Approval.” Journal of Drugs in Dermatology : JDD 7 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c994da3d96aa7eb2bc4f3a341c960911&authtype=sso&custid=ns315887.